What Private Equity Looks for in a Physician-Practice or Telehealth Platform

General information only. This content is not legal, tax, medical or regulatory advice, and reading it does not create an attorney-client, provider or advisory relationship with Melius Wellness LLC. Melius is a business and operational advisory firm, not a law firm, and does not provide legal services. Laws and regulations vary by state and change often, and this content may not reflect recent changes. Consult qualified healthcare counsel and your tax and clinical advisers before acting on it. Last reviewed: October 2026.

Private equity and other institutional investors have been active in physician services and digital health for years. For a founder, that interest can look like an exit, a growth partner or a source of capital for expansion. Whatever the goal, the same truth applies: investors are buying earnings they believe will last, inside a structure they believe will survive scrutiny.

This article describes the areas a buyer or investor typically examines, so operators can prepare early rather than scramble during diligence. It covers the questions operators building toward outside capital should expect.

Why the structure comes first

Because most private equity funds are not physicians, an investment in a medical business often runs through a management services organization (MSO) that contracts with a physician-owned practice, particularly in states that restrict non-physician ownership. If your business already uses that model, investors will examine it closely. If it does not, they will usually require a restructuring before or at closing, and doing that under deal pressure tends to cost the seller leverage.

A clean MSO/PC structure, set up and operated well before a transaction, gives buyers an apples-to-apples picture of what they are buying and removes one of the most common reasons deals slow down. For background on the model itself, see How the MSO/PC model works for telehealth and wellness brands.

Quality of earnings

The financial core of diligence is usually a quality-of-earnings review, often performed by an outside accounting firm. Its job is to answer one question: are the historical earnings real and repeatable?

Expect attention on:

• Revenue composition. Cash-pay, subscription, insurance and one-time revenue are valued differently. Recurring, retained revenue is generally worth more than revenue that depends on constantly winning new patients.
• Unit economics. Cost to win a new patient, retention and churn, gross margin after clinician, pharmacy and shipping costs, and payback period.
• Normalization adjustments. Owner compensation, one-time expenses and related-party arrangements will be adjusted to show what the business earns under new ownership.
• Concentration. Heavy reliance on a single marketing channel, pharmacy, clinician group, payer or product line is a risk investors will price in.
• Clean books by entity. In an MSO/PC model, separate accounting and bank accounts for each entity, with management fees recorded consistently, make the review far easier.

Some sellers commission their own quality-of-earnings work before going to market so there are fewer surprises and a stronger starting position.

Regulatory and compliance diligence

Healthcare diligence goes well beyond financials. Counsel for the investor will usually review:

• Corporate practice of medicine and fee-splitting. Does the MSA keep clinical control with physicians, and does the business actually operate that way?
• Anti-kickback and self-referral exposure. Particularly relevant where any federal health program revenue is involved, and where referral sources have financial relationships with the business.
• Clinician arrangements. Employment and contractor agreements, medical director agreements, collaborating or supervising physician arrangements, licensure in every state where patients are seen, and fair-market-value support for compensation.
• Prescribing and pharmacy relationships. How prescriptions are generated, which pharmacies fill them, whether any compounded products are involved, and whether marketing claims about those products are accurate. See Pharmacy integration for telehealth.
• Marketing and consumer protection. Advertising claims, testimonials, subscription and auto-renewal terms, and consent practices.
• Privacy and security. HIPAA compliance, business associate agreements, data flows to marketing tools, and security controls.

Investors are generally comfortable with businesses that have identified their risks and documented reasonable controls. What concerns them is risk nobody has looked at.

Clinical governance

Investors increasingly want evidence that the clinical side is run with real discipline, not just that the paperwork exists. That typically means written clinical protocols owned by the physician leadership, a quality and safety review process, defined escalation paths for adverse events, prescribing oversight, and a medical director who is genuinely engaged. A strong clinical governance story protects patients and also protects value, because clinical failures are among the fastest ways a healthcare business loses trust.

Technology and data

For telehealth platforms, technology is often a large share of what is being bought. Diligence tends to look at:

• Who owns the code, brand and data, and whether the MSO properly licenses them to the practice.
• Whether clinical records belong to the practice and can be exported.
• How intake, prescribing, pharmacy and billing systems are integrated, and how much depends on manual work.
• Vendor contracts, including change-of-control provisions that could be triggered by a sale.
• Security practices and any history of incidents.

A platform that can add a new state, product line or brand without being rebuilt is easier to underwrite. See Choosing an EMR for a cash-pay telehealth practice for how we think about that layer.

State transaction rules and timing

A growing number of states require notice to, or review by, a state agency before certain healthcare transactions close, and some of these rules reach MSOs and investor-backed businesses, not just traditional providers. Several states have also tightened rules about how much control an MSO or investor may exercise over a practice. These requirements can add weeks or months to a timeline, so it is worth asking counsel early whether any apply to your footprint.

Scalability and the growth story

Beyond the current numbers, investors want to understand how value grows. Common questions include: Can the model expand into more states without restructuring? Is the clinician network deep enough to support growth? Are there additional services or brands that can share the same MSO infrastructure? Is management capable of running a larger organization?

The more of this you can show with operating data rather than projections, the stronger your position.

A practical readiness checklist

• Confirm the MSO/PC structure and MSA reflect how the business actually runs.
• Separate entity financials, and track unit economics monthly.
• Document clinician licensure, agreements and compensation rationale.
• Write down clinical protocols, oversight and quality processes.
• Map data flows and sign business associate agreements where needed.
• Inventory vendor contracts and note change-of-control terms.
• Review marketing claims and subscription terms.
• Ask counsel about state transaction-notice requirements early.

How we help

We help operators get investor-ready on the operating side: structure, workflows, technology, pharmacy relationships and the documentation that shows how it all fits together. We work alongside your legal, tax and transaction advisers. Learn how we engage or contact us.

Frequently asked questions

Does a telehealth business need an MSO structure to raise private equity?

Where state law restricts non-physician ownership of medical practices, investors usually invest through an MSO that contracts with a physician-owned practice. Counsel can confirm what applies to your states.

What is a quality-of-earnings review?

It is a financial analysis, usually by an outside accounting firm, that tests whether a company's reported earnings are accurate, sustainable and properly adjusted for one-time or owner-related items.

When should we start preparing for diligence?

Ideally well before any transaction. Structural fixes, documentation and clean financials take time, and doing them under deal pressure usually weakens the seller's position.